Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-10-11 Sale | 2024-10-15 4:21 pm | Mineralys Therapeutics Inc. | MLYS | Congleton Jon Chief Executive Officer | 15,271 | $13.52 | $206,433 | 895,941 (Direct) | View |
| 2024-07-11 Sale | 2024-07-12 4:36 pm | Mineralys Therapeutics Inc. | MLYS | Congleton Jon Chief Executive Officer | 15,746 | $13.34 | $210,075 | 911,212 (Direct) | View |
| 2024-06-17 Sale | 2024-06-20 5:44 pm | Mineralys Therapeutics Inc. | MLYS | Congleton Jon Chief Executive Officer | 49,313 | $12.01 | $592,022 | 926,958 (Direct) | View |
| 2024-06-12 Sale | 2024-06-14 6:15 pm | Mineralys Therapeutics Inc. | MLYS | Congleton Jon Chief Executive Officer | 72,797 | $12.7 | $924,203 | 976,271 (Direct) | View |
| 2023-11-22 Purchase | 2023-11-27 4:01 pm | Mineralys Therapeutics Inc. | MLYS | Congleton Jon Chief Executive Officer | 4,250 | $5.9661 | $25,356 | 1,049,068 (Direct) | View |
| 2023-09-06 Purchase | 2023-09-08 08:49 am | Mineralys Therapeutics Inc. | MLYS | Congleton Jon Chief Executive Officer | 2,250 | $12.08 | $27,180 | 1,044,818 (Direct) | View |
| 2023-08-17 Purchase | 2023-08-21 4:03 pm | Mineralys Therapeutics Inc. | MLYS | Congleton Jon Chief Executive Officer | 2,250 | $12.1 | $27,225 | 1,042,568 (Direct) | View |
| 2023-08-11 Purchase | 2023-08-11 7:11 pm | Mineralys Therapeutics Inc. | MLYS | Congleton Jon Chief Executive Officer | 2,000 | $12.89 | $25,780 | 1,040,318 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-13 Option Award | 2024-02-15 4:26 pm | N/A 2034-02-13 | Mineralys Therapeutics Inc. | MLYS | Congleton Jon Chief Executive Officer | 425,000 | $0 | 425,000 (Direct) | View |
| 2023-03-17 Option Award | 2023-03-21 6:48 pm | N/A 2033-03-17 | Mineralys Therapeutics Inc. | MLYS | Congleton Jon Chief Executive Officer | 99,800 | $0 | 99,800 (Direct) | View |
| 2023-02-09 Option Award | 2023-02-13 9:01 pm | N/A 2033-02-09 | Mineralys Therapeutics Inc. | MLYS | Congleton Jon Chief Executive Officer | 250,046 | $0 | 250,046 (Direct) | View |
Ownership | 2023-02-09 7:52 pm | N/A N/A | Mineralys Therapeutics Inc. | MLYS | Congleton Jon Chief Executive Officer | 0 | $0 | 1,062,400 (Direct) | View |